CD86 and systemic sclerosis: On the contrary, no significant results were obtained when investigating CD80+CD86+ cells as initial gating strategy, thus confirming previous studies demonstrating a prevalent presence of markers characteristically linked with the alternately activated macrophage phenotype in SSc patients [31, 32].